Literature DB >> 12437274

The development of a simulation model of primary prevention strategies for coronary heart disease.

Hannah Babad1, Colin Sanderson, Bhash Naidoo, Ian White, Duolao Wang.   

Abstract

This paper describes the present state of development of a discrete-event micro-simulation model for coronary heart disease prevention. The model is intended to support health policy makers in assessing the impacts on health care resources of different primary prevention strategies. For each person, a set of times to disease events, conditional on the individual's risk factor profile, is sampled from a set of probability distributions that are derived from a new analysis of the Framingham cohort study on coronary heart disease. Methods used to model changes in behavioural and physiological risk factors are discussed and a description of the simulation logic is given. The model incorporates POST (Patient Oriented Simulation Technique) simulation routines.

Entities:  

Mesh：

Year:  2002        PMID： 12437274     DOI： 10.1023/a:1020330106374

Source DB:  PubMed          Journal:  Health Care Manag Sci        ISSN： 1386-9620


  12 in total

1.  Joint British recommendations on prevention of coronary heart disease in clinical practice. British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society, endorsed by the British Diabetic Association.

Authors: 
Journal:  Heart       Date:  1998-12       Impact factor: 5.994

2.  Is the Framingham risk function valid for northern European populations? A comparison of methods for estimating absolute coronary risk in high risk men.

Authors:  I U Haq; L E Ramsay; W W Yeo; P R Jackson; E J Wallis
Journal:  Heart       Date:  1999-01       Impact factor: 5.994

3.  The health benefits of prevention: a simulation approach.

Authors:  L Gunning-Schepers
Journal:  Health Policy       Date:  1989-07       Impact factor: 2.980

4.  Forecasting coronary heart disease incidence, mortality, and cost: the Coronary Heart Disease Policy Model.

Authors:  M C Weinstein; P G Coxson; L W Williams; T M Pass; W B Stason; L Goldman
Journal:  Am J Public Health       Date:  1987-11       Impact factor: 9.308

5.  Representativeness of the Framingham risk model for coronary heart disease mortality: a comparison with a national cohort study.

Authors:  P E Leaverton; P D Sorlie; J C Kleinman; A L Dannenberg; L Ingster-Moore; W B Kannel; J C Cornoni-Huntley
Journal:  J Chronic Dis       Date:  1987

6.  POHEM--a framework for understanding and modelling the health of human populations.

Authors:  M C Wolfson
Journal:  World Health Stat Q       Date:  1994

7.  The development of a simulation model of the treatment of coronary heart disease.

Authors:  Keith Cooper; Ruth Davies; Paul Roderick; Debbie Chase; James Raftery
Journal:  Health Care Manag Sci       Date:  2002-11

8.  Cardiovascular disease in the Netherlands, 1975 to 1995: decline in mortality, but increasing numbers of patients with chronic conditions.

Authors:  J B Reitsma; J A Dalstra; G J Bonsel; J H van der Meulen; R W Koster; L J Gunning-Schepers; J G Tijssen
Journal:  Heart       Date:  1999-07       Impact factor: 5.994

9.  Risk factors for ischaemic heart disease: the prospective phase of the British Regional Heart Study.

Authors:  A G Shaper; S J Pocock; M Walker; A N Phillips; T P Whitehead; P W Macfarlane
Journal:  J Epidemiol Community Health       Date:  1985-09       Impact factor: 3.710

Review 10.  Established risk factors and coronary artery disease: the Framingham Study.

Authors:  P W Wilson
Journal:  Am J Hypertens       Date:  1994-07       Impact factor: 2.689
View more
  8 in total

1.  Health care productivity.

Authors:  Nick Black; John Browne; John Cairns
Journal:  BMJ       Date:  2006-08-12

Review 2.  A review of health care models for coronary heart disease interventions.

Authors:  K Cooper; S C Brailsford; R Davies; J Raftery
Journal:  Health Care Manag Sci       Date:  2006-11

3.  The development of a simulation model of the treatment of coronary heart disease.

Authors:  Keith Cooper; Ruth Davies; Paul Roderick; Debbie Chase; James Raftery
Journal:  Health Care Manag Sci       Date:  2002-11

4.  A discrete-event simulation of smoking-cessation strategies based on varenicline pivotal trial data.

Authors:  James G Xenakis; Elizabeth T Kinter; K Jack Ishak; Alexandra J Ward; Jeno P Marton; Richard J Willke; Simon Davies; J Jaime Caro
Journal:  Pharmacoeconomics       Date:  2011-06       Impact factor: 4.981

5.  Cost estimation of cardiovascular disease events in the US.

Authors:  Amy K O'Sullivan; Jaime Rubin; Joshua Nyambose; Andreas Kuznik; David J Cohen; David Thompson
Journal:  Pharmacoeconomics       Date:  2011-08       Impact factor: 4.981

6.  Antihypertensive medication versus health promotion for improving metabolic syndrome in preventing cardiovascular events: a success rate-oriented simulation study.

Authors:  Yoichi Ohno; Satomi Shibazaki; Ryuichiro Araki; Takashi Miyazaki; Mayuko Hanyu; Makiko Satoh; Tsuneo Takenaka; Hirokazu Okada; Hiromichi Suzuki
Journal:  BMC Med Inform Decis Mak       Date:  2011-02-13       Impact factor: 2.796

Review 7.  Coronary heart disease policy models: a systematic review.

Authors:  Belgin Unal; Simon Capewell; Julia Alison Critchley
Journal:  BMC Public Health       Date:  2006-08-18       Impact factor: 3.295

8.  Modeling the natural history of fatty liver using lifestyle-related risk factors: Effects of body mass index (BMI) on the life-course of fatty liver.

Authors:  Mika Aizawa; Seiichi Inagaki; Michiko Moriyama; Kenichiro Asano; Masayuki Kakehashi
Journal:  PLoS One       Date:  2019-10-21       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.